Treating the patient, not the disease: in memory of Umberto Veronesi

New ALK inhibitor alectinib halts lung cancer growth more than a year longer than crizotinib, with fewer severe side effects

Adding a second HER2 targeted medicine may lower chance of invasive breast cancer

Global study sets new risk-based standard to personalise chemotherapy for colon cancer after surgery

Low testosterone after testicular cancer could be linked to chronic health problems

Editor's Choice for May 2017

Hallmarks of cancer cell development

Projections of cancer incidence and burden among the HIV-positive population in the United States through 2030

Glycemia positively associated with prostate cancer mortality in non-diabetic men

Mutations in cancer predisposition genes and risk for subsequent neoplasms

Tobacco, lung cancer and non-smoking lung cancers

Oral cancer prevention and awareness in India